BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 20
• 21
• 22
• 23
• 24
• 27
• 28
• 29
• 30

• BioCapital

  Novartis Europharm Ltd Withdraws Its Marketing Authorization Application For Rasival (aliskiren/valsartan)

  September 20, 2010

   · 

  1 min read
• East/West Biopharma Alliances, Including Johnson & Johnson, Merck & Co., Inc. and Beijing Genomics Institute (BGI)

  September 20, 2010

   · 

  1 min read
• BioForest

  Neovasc Inc. Initiates Patient Enrollment in COSIRA Trial of Reducer(TM) Product for Refractory

  September 20, 2010

   · 

  5 min read
• Type 2 Diabetes Patients Taking ‘Januvia’ Experienced Less Hypoglycaemia and No Weight Gain Compared with Glimepiride in New Data Presented at the European Association for the Study of Diabetes (EASD) Annual Meeting

  September 20, 2010

   · 

  9 min read
• Drug Development

  FibroGen, Inc. Announces Chinese State FDA Approval of Phase 1 and 2 Development of FibroGen Oral Anemia Therapy, FG-4592

  September 20, 2010

   · 

  1 min read
• Business

  Biomerix and Synthecon Announce Strategic Distribution Agreement

  September 20, 2010

   · 

  2 min read
• Deals

  Biomagnetics Diagnostics Corporation Completes Merger With Zhuhai Energy and Science Technology LTD

  September 20, 2010

   · 

  1 min read
• FluimediX/MEMSflow ApS Closes Financing Round

  September 20, 2010

   · 

  1 min read
• Policy

  FDA Reviews Takeda Pharmaceutical Co. Ltd.'s Actos Over Bladder Cancer Link

  September 20, 2010

   · 

  1 min read
• Business

  Molecular Response (MRL) Announced Today the Appointment of Cyrus K. Mirsaidi to Chief Executive Officer

  September 20, 2010

   · 

  2 min read